Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Asthma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07323654
What this trial is testing

KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Kymera Therapeutics, Inc. 264
Testing effectiveness (Phase 2)Ended earlyNCT00850642
What this trial is testing

GSK2190915 Moderate to Severe Asthma Study

Who this might be right for
Asthma
GlaxoSmithKline 7
Testing effectiveness (Phase 2)Looking for participantsNCT07342803
What this trial is testing

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

Who this might be right for
Allergic Asthma
Longbio Pharma 200
Testing effectiveness (Phase 2)Ended earlyNCT03745196
What this trial is testing

The Effect of PC945 on Aspergillus or Candida Lung Infections in Patients With Asthma or Chronic Respiratory Diseases

Who this might be right for
AsthmaRespiratory CandidiasisRespiratory Aspergillosis+2 more
Pulmocide Ltd 13
Testing effectiveness (Phase 2)Study completedNCT01494610
What this trial is testing

Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.

Who this might be right for
Asthma
GlaxoSmithKline 60
Post-approval studies (Phase 4)Ended earlyNCT01951378
What this trial is testing

Comparison of Nebulizers in ED in Pediatric Asthma Patients

Who this might be right for
Asthma
Seton Healthcare Family 40
Not applicableStudy completedNCT01362621
What this trial is testing

Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma

Who this might be right for
Moderate to Severe Allergic Asthma
Novartis Pharmaceuticals 474
Not applicableUnknownNCT06151938
What this trial is testing

Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis

Who this might be right for
Allergic Rhinitis Due to House Dust MiteAllergic Asthma
ALK-Abelló A/S 100
Testing effectiveness (Phase 2)Study completedNCT03299686
What this trial is testing

Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Looking for participantsNCT07301255
What this trial is testing

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

Who this might be right for
Asthma
Enveda Therapeutics 50
Not applicableStudy completedNCT00252135
What this trial is testing

Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
Genentech, Inc. 8,023
Post-approval studies (Phase 4)Looking for participantsNCT04743791
What this trial is testing

Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma

Who this might be right for
Asthma
Sally E. Wenzel MD 30
Testing effectiveness (Phase 2)Study completedNCT00096616
What this trial is testing

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 113
Large-scale testing (Phase 3)Study completedNCT01340209
What this trial is testing

Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 285
Testing effectiveness (Phase 2)Study completedNCT01854047
What this trial is testing

An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma

Who this might be right for
Asthma
Sanofi 776
Testing effectiveness (Phase 2)Study completedNCT00280683
What this trial is testing

Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma

Who this might be right for
Asthma
University of California, Davis 20
Testing effectiveness (Phase 2)Ended earlyNCT04946318
What this trial is testing

Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 136
Testing effectiveness (Phase 2)Study completedNCT00317044
What this trial is testing

Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma

Who this might be right for
AsthmaGERD
AstraZeneca 961
Not applicableUnknownNCT02086799
What this trial is testing

Thyroid Hormones Treatment in Asthma Exacerbation

Who this might be right for
Asthma
Rambam Health Care Campus 100
Large-scale testing (Phase 3)WithdrawnNCT00522444
What this trial is testing

Nebulized Magnesium Sulfate in Pediatric Asthma

Who this might be right for
Asthma
Children's Hospital Medical Center, Cincinnati
Next Page